Catheter-directed thrombolysis may offer a safer alternative for high-risk patients with pulmonary embolism

FHS
July 31, 2023
5:52 pm

Pulmonary embolism (PE), a life-threatening condition caused by blood clots in the lung, has long posed a significant risk to patients worldwide.

The Virtual Trip Showcases Veterans Sessions from Psychedelic Science 2023 in Honor of Veterans Day | Psychedelic Invest

Eight conference sessions explore psychedelic research for Veterans. Leading researchers and military professionals discuss promising advances, including trauma support, federal backing, and a pilot study

November 13, 2023

Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data

Share this article Gilead’s Biktarvy has previously been approved by the US FDA as HIV treatment in both adult and paediatric (weighing at least 14kg)

April 29, 2024

IL13R alpha 2 CAR-T by TCR Cure Biopharma Technology for Glioma: Likelihood of Approval

IL13R alpha 2 CAR-T is under clinical development by TCR Cure Biopharma Technology and currently in Phase I for Glioma.

May 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.